| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/07/2002 | WO2001074395A3 Amiodarone-containing parenteral solution |
| 02/07/2002 | WO2001070130A3 Compositions derived from modiolus modiolus and methods for making and using same |
| 02/07/2002 | WO2001062744A3 Substituted piperazine compounds |
| 02/07/2002 | WO2001060806A3 Substituted arylpyrazines |
| 02/07/2002 | WO2001057193A3 Protein c derivatives |
| 02/07/2002 | WO2001056959B1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 02/07/2002 | WO2001046218A3 Fragments of pf4 and pharmaceutical compositions containing the same |
| 02/07/2002 | WO2001044294A3 Compositions and methods for inhibiting endothelial cell proliferation |
| 02/07/2002 | WO2001034206A3 Nucleic acid-containing complex |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | WO2001013900A3 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 02/07/2002 | WO2001010425A3 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 02/07/2002 | WO2000072015A3 Diagnostics and therapeutics for cardiovascular disorders |
| 02/07/2002 | WO2000071753A3 Diagnostics and therapeutics for restenosis |
| 02/07/2002 | WO2000032578A8 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/07/2002 | US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/07/2002 | US20020016471 Inhibitors of p38 |
| 02/07/2002 | US20020016465 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | US20020016463 Partial fatty acid oxidation inhibitors; protect skeletal muscles against damage resulting from trauma or systemic diseases, treat shock conditions, preserve donor tissue and organs used in transplants |
| 02/07/2002 | US20020016370 A therapeutically effective amount of exo-R-mecamylamine or salt, substantially free of exo-S-mecamylamine in combination with a carrier; useful for treating substance addiction |
| 02/07/2002 | US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016360 Method of diminishing the adverse effects of interleukin-2 |
| 02/07/2002 | US20020016354 Treatment of respiratory diseases, convulsions, vascular disorders, renal disorders, urinary disorders, Alzheimer's disease, dysmenorrhea, narcolepsy |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020016321 Novel tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015950 Atherosclerosis-associated genes |
| 02/07/2002 | US20020015700 Inhibiting the interaction of a cell bearing mammalian chemokine receptor 2 (CCR2) with a ligand by binding with antibodies or functional fragments |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | DE10036852A1 Urethanderivate Urethane |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | DE10031391A1 Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie Bicyclic compounds and their use for the prophylaxis and therapy of cerebral ischemia |
| 02/07/2002 | CA2455170A1 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | CA2425889A1 Agonists of follicle stimulating hormone activity |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | CA2418115A1 Imidazole derivatives |
| 02/07/2002 | CA2418071A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417848A1 Compositions and methods for the treatment of anorectal disorders |
| 02/07/2002 | CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417444A1 Nonsteroidal inflammation inhibitors |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417356A1 Directed differentiation of embryonic cells |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417277A1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta. |
| 02/07/2002 | CA2417259A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | CA2415826A1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415789A1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415436A1 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/07/2002 | CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | CA2414623A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | CA2385908A1 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177291A2 Laminin 8 and methods for its use |
| 02/06/2002 | EP1177290A2 Recombinant laminin 5 |
| 02/06/2002 | EP1177289A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 02/06/2002 | EP1177217A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 02/06/2002 | EP1177208A1 Spray drying of thrombin inhibitors |
| 02/06/2002 | EP1177204A2 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 02/06/2002 | EP1177200A1 Ligands for metabotropic glutamate receptors |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177186A1 Ureas and their use as cell adhesion modulators |
| 02/06/2002 | EP1177185A1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 02/06/2002 | EP1177181A1 Substituted bicyclic compounds |
| 02/06/2002 | EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP1176985A2 Enzymatically activated polymeric drug conjugates |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176972A1 Use of phyllanthus for targeted stimulation of the immune system |